Management of inhibitors to factor VIII.
D001778:Blood Coagulation Disorders / Q000628:therapy*; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006467:Hemophilia A / Q000276:immunology; D006470:Hemorrhage / Q000628:therapy; D006487:Hemostasis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011516:Prothrombin / Q000008:administration & dosage / Q000009:adverse effects
D007166:Immunosuppressive Agents; D011516:Prothrombin; D005169:Factor VIII